STOCK TITAN

Trade Desk reprices CEO stock options to $12.26

Options expiring April 24, 2033, April 15, 2035 and March 3, 2036 vest monthly in 1/48 installments, subject to continued employment.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Trade Desk, Inc. President and CEO Jeffrey Terry Green reported a one-time stock-option repricing effective October 19, 2026, with option dispositions to the issuer and corresponding acquisitions. The repriced tranches cover 215,720, 215,696, 450,045 and 737,028 Class A shares. Their prior exercise prices were $74.8980, $61.4600, $49.2400 and $25.0000, respectively; each was reduced to $12.26. The repricing did not change the option share counts, expiration dates or vesting schedules. Stockholders approved it on October 19, 2026. To exercise at the new price, Green must remain in service through April 19, 2027, except in the event of termination by the issuer without cause.

Insider Green Jeffrey Terry
Role President and CEO
Type Security Shares Price Value
Disposition Employee Stock Option (Right to Buy) F1, F3, F2 215,720 -- --
Grant/Award Employee Stock Option (Right to Buy) F3, F2 215,720 -- --
Disposition Employee Stock Option (Right to Buy) F3, F4 215,696 -- --
Grant/Award Employee Stock Option (Right to Buy) F3, F4 215,696 -- --
Disposition Employee Stock Option (Right to Buy) F3, F5 450,045 -- --
Grant/Award Employee Stock Option (Right to Buy) F3, F5 450,045 -- --
Disposition Employee Stock Option (Right to Buy) F3, F6 737,028 -- --
Grant/Award Employee Stock Option (Right to Buy) F3, F6 737,028 -- --
Holdings After Transaction: Employee Stock Option (Right to Buy) — 1,618,489 contracts (Direct)
Footnotes (6)
  1. F1. This option was previously reported as covering 21,572 shares at an exercise price of $748.98 per share but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
  2. F2. The option is fully vested and exercisable.
  3. F3. The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause.
  4. F4. The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates.
  5. F5. The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates.
  6. F6. The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates.
Underlying shares in repriced option tranche 215,720 shares Prior exercise price $74.8980; expiration April 29, 2031.
Underlying shares in repriced option tranche 215,696 shares Prior exercise price $61.4600; expiration April 24, 2033.
Underlying shares in repriced option tranche 450,045 shares Prior exercise price $49.2400; expiration April 15, 2035.
Underlying shares in repriced option tranche 737,028 shares Prior exercise price $25.0000; expiration March 3, 2036.
Repriced exercise price $12.26 per share New exercise price for the repriced options.
Option Repricing financial
"one-time stock option repricing (the "Option Repricing")"
exercise price financial
"reduce the exercise price to $12.26 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting schedule financial
"There is no change to the number of shares, the expiration dates or the vesting schedule"
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.
Vesting Commencement Date financial
"the Vesting Commencement Date ("VCD")"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
fully vested and exercisable financial
"The option is fully vested and exercisable."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What changed in Jeffrey Green's TTD stock options?

The reported repricing covered four option tranches for 215,720, 215,696, 450,045 and 737,028 underlying Class A shares. The prior exercise prices were $74.8980, $61.4600, $49.2400 and $25.0000, respectively, and each was reduced to $12.26.

How do the TTD repriced option tranches vest?

The options expiring April 24, 2033, April 15, 2035 and March 3, 2036 vest 1/48 on each monthly anniversary, subject to continued employment through the applicable vesting dates. The option expiring April 29, 2031 is fully vested and exercisable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Green Jeffrey Terry

(Last)(First)(Middle)
C/O THE TRADE DESK, INC.
42 NORTH CHESTNUT STREET

(Street)
VENTURA CALIFORNIA 93001

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Trade Desk, Inc. [ TTD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/19/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy)$74.898(1)10/19/2026D215,720 (2)04/29/2031Class A Common Stock215,720(3)0D
Employee Stock Option (Right to Buy)$12.2610/19/2026A215,720 (2)04/29/2031Class A Common Stock215,720(3)215,720D
Employee Stock Option (Right to Buy)$61.4610/19/2026D215,696 (4)04/24/2033Class A Common Stock215,696(3)0D
Employee Stock Option (Right to Buy)$12.2610/19/2026A215,696 (4)04/24/2033Class A Common Stock215,696(3)215,696D
Employee Stock Option (Right to Buy)$49.2410/19/2026D450,045 (5)04/15/2035Class A Common Stock450,045(3)0D
Employee Stock Option (Right to Buy)$12.2610/19/2026A450,045 (5)04/15/2035Class A Common Stock450,045(3)450,045D
Employee Stock Option (Right to Buy)$2510/19/2026D737,028 (6)03/03/2036Class A Common Stock737,028(3)0D
Employee Stock Option (Right to Buy)$12.2610/19/2026A737,028 (6)03/03/2036Class A Common Stock737,028(3)737,028D
Explanation of Responses:
1. This option was previously reported as covering 21,572 shares at an exercise price of $748.98 per share but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
2. The option is fully vested and exercisable.
3. The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") under the Issuer's 2025 Incentive Award Plan effective on October 19, 2026 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $12.26 per share, the closing price of the Issuer's Class A Common Stock on the Repricing Date. There is no change to the number of shares, the expiration dates or the vesting schedule of the repriced options. The Option Repricing was approved by the Issuer's stockholders on October 19, 2026. In order to exercise the repriced options at the new exercise price, the Reporting Person is required to remain in service with the Issuer through April 19, 2027, except for a termination by the Issuer without cause.
4. The option was granted on April 24, 2023, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates.
5. The option was granted on April 15, 2025, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates.
6. The option was granted on March 3, 2026, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates.
Remarks:
/s/ Kelli Faerber, Attorney-in-Fact for Jeffrey Terry Green10/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading